130 related articles for article (PubMed ID: 11366681)
1. 5-FU for maintenance therapy of cervical lesions.
Hanna L
BETA; 1999 Apr; 12(2):17. PubMed ID: 11366681
[TBL] [Abstract][Full Text] [Related]
2. Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial.
Maiman M; Watts DH; Andersen J; Clax P; Merino M; Kendall MA
Obstet Gynecol; 1999 Dec; 94(6):954-61. PubMed ID: 10576182
[TBL] [Abstract][Full Text] [Related]
3. 5-FU for cervical intraepithelia neoplasia.
AIDS Patient Care STDS; 2000 Feb; 14(2):104. PubMed ID: 10743527
[No Abstract] [Full Text] [Related]
4. Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial.
Rahangdale L; Lippmann QK; Garcia K; Budwit D; Smith JS; van Le L
Am J Obstet Gynecol; 2014 Apr; 210(4):314.e1-314.e8. PubMed ID: 24384495
[TBL] [Abstract][Full Text] [Related]
5. Anti-cancer agents. Cream reduces reappearance of cervical lesions.
TreatmentUpdate; 2000 Feb; 12(1):5-6. PubMed ID: 12125629
[No Abstract] [Full Text] [Related]
6. Topical 5-FU reduces CIN recurrence.
Newsline People AIDS Coalit N Y; 1999; ():31. PubMed ID: 11367342
[TBL] [Abstract][Full Text] [Related]
7. [Topical 5-fluorouracil for treatment of vaginal intraepithelial neoplasms].
González Sánchez JL; Flores Murrieta G; Chávez Brambila J; Deolarte Manzano JM; Andrade Manzano AF
Ginecol Obstet Mex; 2002 May; 70():244-7. PubMed ID: 12148464
[TBL] [Abstract][Full Text] [Related]
8. Retinoids for vulvar dysplasia in the HIV-infected patient.
Del Priore G; Herron MM
Int J Gynaecol Obstet; 1996 Oct; 55(1):77-8. PubMed ID: 8910089
[No Abstract] [Full Text] [Related]
9. Isotretinoin for low-grade cervical dysplasia in human immunodeficiency virus-infected women.
Robinson WR; Andersen J; Darragh TM; Kendall MA; Clark R; Maiman M
Obstet Gynecol; 2002 May; 99(5 Pt 1):777-84. PubMed ID: 11978287
[TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial evaluating a novel cytotoxic drug delivery system for the treatment of cervical intraepithelial neoplasia.
Sidhu HK; Price JH; McCarron PA; McCafferty DF; Woolfson AD; Biggart D; Thompson W
Br J Obstet Gynaecol; 1997 Feb; 104(2):145-9. PubMed ID: 9070128
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome of cervical neoplasia in HIV-infected women in the era of highly active antiretroviral therapy.
Robinson WR; Freeman D
AIDS Patient Care STDS; 2002 Feb; 16(2):61-5. PubMed ID: 11874637
[TBL] [Abstract][Full Text] [Related]
12. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.
Heard I; Schmitz V; Costagliola D; Orth G; Kazatchkine MD
AIDS; 1998 Aug; 12(12):1459-64. PubMed ID: 9727566
[TBL] [Abstract][Full Text] [Related]
13. Topical 5-fluorouracil treatment of transformation zone intraepithelial neoplasia of cervix and vagina.
Pride GL; Chuprevich TW
Obstet Gynecol; 1982 Oct; 60(4):467-72. PubMed ID: 7121934
[TBL] [Abstract][Full Text] [Related]
14. Topical 5-Fluorouracil for Women With High-Grade Vaginal Intraepithelial Neoplasia.
Fiascone S; Vitonis AF; Feldman S
Obstet Gynecol; 2017 Dec; 130(6):1237-1243. PubMed ID: 29112645
[TBL] [Abstract][Full Text] [Related]
15. Correspondence re: M. Follen et al., a randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.
Formelli F
Clin Cancer Res; 2002 May; 8(5):1310-2; author reply 1313. PubMed ID: 12006553
[No Abstract] [Full Text] [Related]
16. Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women.
Nappi L; Carriero C; Bettocchi S; Herrero J; Vimercati A; Putignano G
Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):226-32. PubMed ID: 16054967
[TBL] [Abstract][Full Text] [Related]
17. Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia--a pilot study.
Suh-Burgmann E; Sivret J; Duska LR; Del Carmen M; Seiden MV
Gynecol Obstet Invest; 2003; 55(1):25-31. PubMed ID: 12624548
[TBL] [Abstract][Full Text] [Related]
18. Cervical neoplastic lesions in relation to CD4 T-lymphocyte counts and antiretroviral therapy among women with clinical stage 1 HIV in Yunnan, China.
Zhang DY; Chen W; Zhang HY; Lv SQ; Lu XN; Tao YP; Zhang M; Liu JF; Yang M; Qiao YL; Braithwaite D
Kaohsiung J Med Sci; 2020 Jun; 36(6):450-459. PubMed ID: 31913555
[TBL] [Abstract][Full Text] [Related]
19. Cervical screening and management of cervical intraepithelial neoplasia in HIV-positive women.
Danso D; Lyons F; Bradbeer C
Int J STD AIDS; 2006 Sep; 17(9):579-84; quiz 585-7. PubMed ID: 16942648
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.
Holmes MM; Weaver SH; Vermillion ST
Infect Dis Obstet Gynecol; 1999; 7(4):186-9. PubMed ID: 10449266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
